1. New therapeutic targets for rheumatoid arthritis

   • H.J. Dinant
   • B.A.C. Dijkmans

   OriginalPaper Pages: 49 - 59

2. Cost‐effectiveness analysis of tropisetron vs. chlorpromazine‐dexamethasone in the control of acute emesis induced by highly emetogenic chemotherapy in children

   • I. Tejedor
   • A. Idoate
   • L. Sierrasesumaga

   OriginalPaper Pages: 60 - 68

3. The importance that community pharmacists in Malta place on the introduction of pharmaceutical care

   • Maria Cordina
   • James C. McElnay
   • Carmel M. Hughes

   OriginalPaper Pages: 69 - 73

4. Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitals

   • R. Fijn
   • L.T.W. de Jong‐van den Berg
   • J.R.B.J. Brouwers

   OriginalPaper Pages: 74 - 79

5. Prescription data as a tool in pharmacotherapy audit (I) general considerations

   • C.S. de Vries
   • ThFJ de Tromp
   • W. Blijleven

   OriginalPaper Pages: 80 - 84

6. Prescription data as a tool in pharmacotherapy audit (II) the development of an instrument

   • C.S. de Vries
   • P.B. van den Berg
   • W. Blijleven

   OriginalPaper Pages: 85 - 90

7. Flurbiprofen, S(+), eyedrops: formulation, enantiomeric assay, shelflife and pharmacology

   • Adriaan A. van Sorge
   • Peter H. Wijnen
   • Nicolaas J. van Haeringen

   OriginalPaper Pages: 91 - 95

8. Drugs up in smoke: a study of caseated drugs in Sweden

   • Dag Isacson
   • Christin Olofsson

   OriginalPaper Pages: 96 - 99